{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:13:37Z","timestamp":1792808017113,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:00:00Z","timestamp":1717459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:00:00Z","timestamp":1717459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C61296\/A27223"],"award-info":[{"award-number":["C61296\/A27223"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C61296\/A27223"],"award-info":[{"award-number":["C61296\/A27223"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C61296\/A27223"],"award-info":[{"award-number":["C61296\/A27223"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["PPRPGM-Nov20\\100002"],"award-info":[{"award-number":["PPRPGM-Nov20\\100002"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["PPRPGM-Nov20\\100002"],"award-info":[{"award-number":["PPRPGM-Nov20\\100002"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute for Health and Care Research Exeter Biomedical Research Centre"},{"name":"NIHR Cambridge Biomedical Research Centre"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2024,6,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The CanRisk tool, which operationalises the Breast and Ovarian Analysis of Disease Incidence and Carrier Estimation Algorithm (BOADICEA) is used by Clinical Geneticists, Genetic Counsellors, Breast Oncologists, Surgeons and Family History Nurses for breast cancer risk assessments both nationally and internationally. There are currently no guidelines with respect to the day-to-day clinical application of CanRisk and differing inputs to the model can result in different recommendations for practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      To address this gap, the UK Cancer Genetics Group in collaboration with the Association of Breast Surgery and the CanGene-CanVar programme held a workshop on 16\n                      <jats:sup>th<\/jats:sup>\n                      of May 2023, with the aim of establishing best practice guidelines.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Using a pre-workshop survey followed by structured discussion and in-meeting polling, we achieved consensus for UK best practice in use of CanRisk in making recommendations for breast cancer surveillance, eligibility for genetic testing and the input of available information to undertake an individualised risk assessment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Whilst consensus recommendations were achieved,\u00a0the meeting highlighted some of the barriers limiting the use of CanRisk in clinical practice and identified areas that require further work and collaboration with relevant national bodies and policy makers to incorporate wider use of CanRisk into routine breast cancer risk assessments.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41416-024-02733-4","type":"journal-article","created":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T08:03:04Z","timestamp":1717488184000},"page":"2027-2036","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Joint ABS-UKCGG-CanGene-CanVar consensus regarding the use of CanRisk in clinical practice"],"prefix":"10.1038","volume":"130","author":[{"given":"Olga","family":"Tsoulaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7880-0628","authenticated-orcid":false,"given":"Marc","family":"Tischkowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonis C.","family":"Antoniou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Musgrave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Rea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7264-6201","authenticated-orcid":false,"given":"Ashu","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey","family":"Irvine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Holcombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Eccles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1734-5772","authenticated-orcid":false,"given":"Clare","family":"Turnbull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramsey","family":"Cutress","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Meeting Attendees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avgi","family":"Andreou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Badran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Berlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathie","family":"Binysh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Cleaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Corbett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemarie","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"DeSouza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Evers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Ficorella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzannah","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Forman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rochelle","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steph","family":"Greville-Heygate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie","family":"Hammond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Hart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Hawkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jude","family":"Hayward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie","family":"Holliday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antony","family":"Howell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Hutchison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqui","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalyn","family":"Jewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Kavanaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Kemp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Kiesel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajith","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Lalloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zosia","family":"Miedzybrodzka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennie","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sian","family":"Nisbet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Della","family":"Ogunleye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anbalakan","family":"Paramasivam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Searle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eamon","family":"Sheridan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Side","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverley","family":"Speight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Teh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Thorpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Whaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siobhan","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma R.","family":"Woodward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Youngs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Archer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3303-8713","authenticated-orcid":false,"given":"Helen","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,4]]},"reference":[{"key":"2733_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"2733_CR2","unstructured":"Cancer Research UK. Breast cancer statistics. https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/breast-cancer#heading-Three. Accessed 20 Nov 2023."},{"key":"2733_CR3","doi-asserted-by":"crossref","unstructured":"Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M The benefits and harms of breast cancer screening: an independent reviewThe Independent UK Panel on Breast Cancer Screening. 2013 [cited 2023 Nov 20]; Available from: www.bjcancer.com.","DOI":"10.1038\/bjc.2013.177"},{"key":"2733_CR4","unstructured":"Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer Clinical guideline. 2013 [cited 2023 Nov 20]; Available from: www.nice.org.uk\/guidance\/cg164."},{"key":"2733_CR5","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1038\/s41436-018-0406-9","volume":"21","author":"A Lee","year":"2019","unstructured":"Lee A, Mavaddat N, Wilcox AN, Cunningham AP, Carver T, Hartley S, et al. BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors. Genet Med. 2019;21:1708\u201318.","journal-title":"Genet Med"},{"key":"2733_CR6","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/sim.1668","volume":"23","author":"J Tyrer","year":"2004","unstructured":"Tyrer J, Duffy SW, Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Stat Med. 2004;23:1111\u201330.","journal-title":"Stat Med"},{"key":"2733_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-021-01399-7","volume":"23","author":"P Pal Choudhury","year":"2021","unstructured":"Pal Choudhury P, Brook MN, Hurson AN, Lee A, Mulder CV, Coulson P, et al. Comparative validation of the BOADICEA and Tyrer-Cuzick breast cancer risk models incorporating classical risk factors and polygenic risk in a population-based prospective cohort of women of European ancestry. Breast Cancer Res. 2021;23:22.","journal-title":"Breast Cancer Res"},{"key":"2733_CR8","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/s41416-023-02145-w","volume":"128","author":"JA Usher-Smith","year":"2023","unstructured":"Usher-Smith JA, Hindmarch S, French DP, Tischkowitz M, Moorthie S, Walter FM, et al. Proactive breast cancer risk assessment in primary care: a review based on the principles of screening. Br J Cancer. 2023;128:1636\u201346.","journal-title":"Br J Cancer"},{"key":"2733_CR9","doi-asserted-by":"publisher","first-page":"e0229999","DOI":"10.1371\/journal.pone.0229999","volume":"15","author":"S Archer","year":"2020","unstructured":"Archer S, Babb de Villiers C, Scheibl F, Carver T, Hartley S, Lee A, et al. Evaluating clinician acceptability of the prototype CanRisk tool for predicting risk of breast and ovarian cancer: A multi-methods study. PLoS One. 2020;15:e0229999.","journal-title":"PLoS One"},{"key":"2733_CR10","doi-asserted-by":"publisher","first-page":"e586","DOI":"10.3399\/BJGP.2022.0643","volume":"73","author":"S Archer","year":"2023","unstructured":"Archer S, Donoso FS, Carver T, Yue A, Cunningham AP, Ficorella L, et al. Exploring the barriers to and facilitators of implementing CanRisk in primary care: a qualitative thematic framework analysis. Br J Gen Pract. 2023;73:e586\u201396.","journal-title":"Br J Gen Pract"},{"key":"2733_CR11","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1158\/1055-9965.EPI-20-1319","volume":"30","author":"T Carver","year":"2021","unstructured":"Carver T, Hartley S, Lee A, Cunningham AP, Archer S, Babb de Villiers C, et al. CanRisk Tool\u2014a web interface for the prediction of breast and ovarian cancer risk and the likelihood of carrying genetic pathogenic variants. Cancer Epidemiol, Biomark Prev. 2021;30:469\u201373.","journal-title":"Cancer Epidemiol, Biomark Prev"},{"key":"2733_CR12","doi-asserted-by":"crossref","unstructured":"Yang X, Eriksson M, Czene K, Lee A, Leslie G, Lush M, et al. Prospective validation of the BOADICEA multifactorial breast cancer risk prediction model in a large prospective cohort study. J Med Genet [Internet]. 1196 [cited 2023 Nov 23];59:1196\u2013205. Available from: www.canrisk.org.","DOI":"10.1136\/jmg-2022-108806"},{"key":"2733_CR13","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1136\/jmedgenet-2022-108471","volume":"59","author":"A Lee","year":"2022","unstructured":"Lee A, Mavaddat N, Cunningham A, Carver T, Ficorella L, Archer S, et al. Enhancing the BOADICEA cancer risk prediction model to incorporate new data on RAD51C, RAD51D, BARD1 updates to tumour pathology and cancer incidence. J Med Genet. 2022;59:1206\u201318.","journal-title":"J Med Genet"},{"key":"2733_CR14","doi-asserted-by":"publisher","unstructured":"Baek M\u00f8ller N, Sofie Boonen D, Simone Feldner E, Hao Q, Larsen M, Laenkholm AV, et al. Validation of the BOADICEA model for predicting the likelihood of carrying pathogenic variants in eight breast and ovarian cancer susceptibility genes. 123AD [cited 2023 Nov 21]; Available from: https:\/\/doi.org\/10.1038\/s41598-023-35755-8.","DOI":"10.1038\/s41598-023-35755-8"},{"key":"2733_CR15","unstructured":"CanRisk. https:\/\/canrisk.org. Accessed 12 Dec 2023."},{"key":"2733_CR16","unstructured":"UK Cancer Genetics Group (UKCGG). Available from: https:\/\/www.ukcgg.org\/."},{"key":"2733_CR17","unstructured":"Cancer Research UK (CRUK) Funded CanGene-CanVar research programme (CGCV). Available from: https:\/\/www.cangene-canvaruk.org\/."},{"key":"2733_CR18","unstructured":"Centre for Cancer Genetic Epidemiology. Available from: https:\/\/ccge.medschl.cam.ac.uk\/."},{"key":"2733_CR19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1136\/jmedgenet-2020-106876","volume":"58","author":"H Hanson","year":"2020","unstructured":"Hanson H, Brady AF, Crawford G, Eeles RA, Gibson S, Jorgensen M, et al. UKCGG Consensus Group guidelines for the management of patients with constitutional TP53 pathogenic variants. J Med Genet. 2020;58:135\u20139.","journal-title":"J Med Genet"},{"key":"2733_CR20","unstructured":"Cisco Systems, W Slido. 2023 [accessed 20 Nov 2023]. Available from: https:\/\/www.slido.com."},{"key":"2733_CR21","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/S1470-2045(18)30902-1","volume":"20","author":"MB Terry","year":"2019","unstructured":"Terry MB, Liao Y, Whittemore AS, Leoce N, Buchsbaum R, Zeinomar N, et al. 10-year performance of four models of breast cancer risk: a validation study. Lancet Oncol [Internet]. 2019;20:504\u201317. http:\/\/www.thelancet.com\/article\/S1470204518309021\/fulltext.","journal-title":"Lancet Oncol [Internet]"},{"key":"2733_CR22","unstructured":"Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer. NICE Clinical guideline [CG164]. 2013 [cited 2023 Nov 20]; Available from: www.nice.org.uk\/guidance\/cg164."},{"key":"2733_CR23","unstructured":"Rahman A, Hlaing T BJGP OPEN Proactive familial cancer risk assessment: A UK primary care study. 2023 [cited 2023 Dec 4]; Available from: http:\/\/creativecommons.org\/licenses\/by\/4.0\/."},{"key":"2733_CR24","unstructured":"TrakGene. https:\/\/www.trakgene.com\/. Accessed 07 Dec 2023."},{"key":"2733_CR25","unstructured":"PHENOTIPS. https:\/\/phenotips.com\/. Accessed 07 Dec 2023."},{"key":"2733_CR26","unstructured":"FamGenix. https:\/\/famgenix.com\/. Accessed 07 Dec 2023."},{"key":"2733_CR27","doi-asserted-by":"publisher","unstructured":"Fallowfield L, Solis-Trapala I, Starkings R, May S, Matthews L, Eccles D, et al. Talking about Risk, UncertaintieS of Testing IN Genetics (TRUSTING): development and evaluation of an educational programme for healthcare professionals about BRCA1 & BRCA2 testing. Br J Cancer [Internet]. 2022 [cited 2023 Dec 7];127. Available from: https:\/\/doi.org\/10.1038\/s41416-022-01871-x.","DOI":"10.1038\/s41416-022-01871-x"},{"key":"2733_CR28","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1080\/10810730.2020.1745963","volume":"25","author":"SJ Hong","year":"2020","unstructured":"Hong SJ. Uncertainty in the process of communicating cancer-related genetic risk information with patients: a scoping review. J Health Commun. 2020;25:251\u201370.","journal-title":"J Health Commun"},{"key":"2733_CR29","doi-asserted-by":"publisher","first-page":"333","DOI":"10.2147\/PPA.S232941","volume":"14","author":"L Henneman","year":"2020","unstructured":"Henneman L, van Asperen CJ, Oosterwijk JC, Menko FH, Claassen L, Timmermans DR. Do preferred risk formats lead to better understanding? a multicenter controlled trial on communicating familial breast cancer risks using different risk formats. Patient Prefer Adherence. 2020;14:333\u201342.","journal-title":"Patient Prefer Adherence"},{"key":"2733_CR30","unstructured":"Breast screening: very high risk women surveillance protocols guidance https:\/\/www.gov.uk\/government\/publications\/breast-screening-higher-risk-women-surveillance-protocols. Accessed 03 April 2024"},{"key":"2733_CR31","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.ajhg.2023.02.003","volume":"110","author":"A Morra","year":"2023","unstructured":"Morra A, Mavaddat N, Muranen TA, Ahearn TU, Allen J, Andrulis IL, et al. The impact of coding germline variants on contralateral breast cancer risk and survival. Am J Hum Genet. 2023;110:475\u201386.","journal-title":"Am J Hum Genet"},{"key":"2733_CR32","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1200\/JCO.22.01239","volume":"41","author":"S Yadav","year":"2023","unstructured":"Yadav S, Boddicker NJ, Na J, Polley EC, Hu C, Hart SN, et al. Contralateral breast cancer risk among carriers of germline pathogenic variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2. J Clin Oncol. 2023;41:1703\u201313.","journal-title":"J Clin Oncol"},{"key":"2733_CR33","unstructured":"NHSE National Genomic Test Directory Available from: https:\/\/www.england.nhs.uk\/publication\/national-genomic-test-directories\/."},{"key":"2733_CR34","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1136\/jmg.2005.031989","volume":"42","author":"DGR Evans","year":"2005","unstructured":"Evans DGR. Update on the Manchester Scoring System for BRCA1 and BRCA2 testing. J Med Genet. 2005;42:e39.","journal-title":"J Med Genet"},{"key":"2733_CR35","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1136\/jmg.2003.017996","volume":"41","author":"DGR Evans","year":"2004","unstructured":"Evans DGR. A new scoring system for the chances of identifying a BRCA1\/2 mutation outperforms existing models including BRCAPRO. J Med Genet. 2004;41:474\u201380.","journal-title":"J Med Genet"},{"key":"2733_CR36","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1136\/jmedgenet-2017-104584","volume":"54","author":"DG Evans","year":"2017","unstructured":"Evans DG, Harkness EF, Plaskocinska I, Wallace AJ, Clancy T, Woodward ER, et al. Pathology update to the Manchester Scoring System based on testing in over 4000 families. J Med Genet. 2017;54:674\u201381.","journal-title":"J Med Genet"},{"key":"2733_CR37","unstructured":"CanVIG-UK Resources. https:\/\/www.cangene-canvaruk.org\/canvig-uk-report-templates. Accessed 12 Dec 2023."},{"key":"2733_CR38","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/j.gim.2022.03.009","volume":"24","author":"D Gareth","year":"2022","unstructured":"Gareth D, Evans R, Van Veen EM, Harkness EF, Brentnall AR, Astley SM, et al. ARTICLE Breast cancer risk stratification in women of screening age: Incremental effects of adding mammographic density, polygenic risk, and a gene panel. Genet Med [Internet]. 2022;24:1485\u201394. http:\/\/creativecommons.org\/licenses\/by\/4.0\/.","journal-title":"Genet Med [Internet]"},{"key":"2733_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-019-1138-8","volume":"21","author":"CM Vachon","year":"2019","unstructured":"Vachon CM, Scott CG, Tamimi RM, Thompson DJ, Fasching PA, Stone J, et al. Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk. Breast Cancer Res. 2019;21:68.","journal-title":"Breast Cancer Res"},{"key":"2733_CR40","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.breast.2023.01.003","volume":"67","author":"E Roberts","year":"2023","unstructured":"Roberts E, Howell S, Evans DG. Polygenic risk scores and breast cancer risk prediction. Breast. 2023;67:71\u20137.","journal-title":"Breast"},{"key":"2733_CR41","first-page":"309","volume":"36","author":"FS Douglas","year":"1999","unstructured":"Douglas FS, O\u2019Dair LC, Robinson M, Evans DG, Lynch SA. The accuracy of diagnoses as reported in families with cancer: a retrospective study. J Med Genet. 1999;36:309\u201312.","journal-title":"J Med Genet"},{"key":"2733_CR42","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/sj.ejhg.5200441","volume":"8","author":"RH Sijmons","year":"2000","unstructured":"Sijmons RH, Boonstra AE, Reefhuis J, Hordijk-Hos JM, de Walle HE, Oosterwijk JC, et al. Accuracy of family history of cancer: clinical genetic implications. Eur J Hum Genet. 2000;8:181\u20136.","journal-title":"Eur J Hum Genet"},{"key":"2733_CR43","unstructured":"Ovarian cancer: identifying and managing familial and genetic risk. NICE guideline [NG241]."},{"key":"2733_CR44","doi-asserted-by":"crossref","unstructured":"Marc Tischkowitz. Assessing the impact of personalised risk estimates on the uptake and timing of risk management options in women who have inherited a change in genes associated with an increased risk of breast and ovarian cancer (Accessed 23 Nov 2023).","DOI":"10.1186\/ISRCTN15331714"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-024-02733-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-024-02733-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-024-02733-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T07:09:43Z","timestamp":1718608183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-024-02733-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,4]]},"references-count":44,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,6,29]]}},"alternative-id":["2733"],"URL":"https:\/\/doi.org\/10.1038\/s41416-024-02733-4","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,4]]},"assertion":[{"value":"6 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"RC received institutional research funding from SECA and Astra-Zeneca. ACA is listed as creator of the BOADICEA model that was licensed by Cambridge Enterprise (University of Cambridge). All other authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}